-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, INMc8hkdAdQWqHrJHq8BiUQNiCncD+5OmRT8mq1/nLCRPYysZm5FNlCC5jOUhrPT 86/hzdOARchGJMlih6ykQA== 0000914062-04-000326.txt : 20040701 0000914062-04-000326.hdr.sgml : 20040701 20040701100534 ACCESSION NUMBER: 0000914062-04-000326 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040630 FILED AS OF DATE: 20040701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEVEVINO DANIEL J CENTRAL INDEX KEY: 0001186458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13165 FILM NUMBER: 04893184 MAIL ADDRESS: STREET 1: R D #1 BOX 36 CITY: AVONMORE STATE: PA ZIP: 15618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRYOLIFE INC CENTRAL INDEX KEY: 0000784199 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 592417093 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W STREET 2: STE 142 CITY: KENNESAW STATE: GA ZIP: 30144 BUSINESS PHONE: 7704193355 MAIL ADDRESS: STREET 1: 1655 ROBERTS BOULEVARD N W STREET 2: STE 142 CITY: KENNESAW STATE: GA ZIP: 30144 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-06-30 0000784199 CRYOLIFE INC CRY 0001186458 BEVEVINO DANIEL J RESPIRONICS, INC. 1010 MURRY RIDGE LANE MURRYSVILLE PA 15668 1 0 0 0 Stock Option 5.27 2004-06-30 4 A 0 10000 0 A 2004-06-30 2009-06-30 Common Stock 10000 10000 D Daniel J. Bevevino 2004-06-30 EX-24 2 bevevinoconfstmt.htm CONFIRMING STATEMENT

CONFIRMING STATEMENT

This Statement confirms that the undersigned has authorized and designated the Chief Executive Officer or the Chief Financial Officer of CryoLife, Inc. to execute and file on the undersigned’s behalf all Forms 3, 4 and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of CryoLife, Inc. The authority of the Chief Executive Officer or the Chief Financial Officer of CryoLife, Inc. under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4 and 5 with regard to the undersigned’s ownership of or transactions in securities of CryoLife, Inc., unless earlier revoked in writing. The undersigned acknowledges that the Chief Executive Officer or the Chief Financial Officer of CryoLife, Inc. are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

Dated as of December 12, 2003	/s/ Daniel J. Bevevino
	[Director]

-----END PRIVACY-ENHANCED MESSAGE-----